These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10550904)

  • 1. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
    Gorter RW; van Wely M; Reif M; Stoss M
    Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
    van Wely M; Stoss M; Gorter RW
    Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
    Stoss M; van Wely M; Musielsky H; Gorter RW
    Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
    Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
    Elsässer-Beile U; Leiber C; Wolf P; Lucht M; Mengs U; Wetterauer U
    J Urol; 2005 Jul; 174(1):76-9. PubMed ID: 15947582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
    Cebović T; Spasić S; Popović M
    Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of mistletoe extracts (Viscum album L.). I. Affinity chromatography of mistletoe extracts on immobilized plasma proteins.
    Franz H; Haustein B; Luther P; Kuropka U; Kindt A
    Acta Biol Med Ger; 1977; 36(1):113-7. PubMed ID: 878740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts.
    Bauer C; Oppel T; Ruëff F; Przybilla B
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):86-9. PubMed ID: 15702822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
    Huber R; Klein R; Berg PA; Lüdtke R; Werner M
    J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subchronic toxicity of Viscum cruciatum Sieber].
    Gallego Quevedo MT; Ayuso González MJ; Garcia Román A
    Ann Pharm Fr; 1990; 48(4):192-9. PubMed ID: 2080835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
    Stoss M; Gorter RW
    Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.